MedTrace Logo

MicroTrans - A Multicenter Registry of Fecal Microbiota Transplantation

NCT02681068 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2017-05-04

No results posted yet for this study

Summary

The registry collects cases of patients received fecal microbiota transplantation (FMT) due to Clostridium difficile associated diarrhea (CDAD). The main objective of this study is to analyze the safety and effectiveness of FMT. Furthermore, data analysis will be used to implement a standardization of FMT in German hospitals and improve patient outcome. Therefore, a detailed description of completions of FMT are documented on our web-based survey platform www.ClinicalSurveys.net.

Conditions

  • Clostridium Infections

Interventions

OTHER

Fecal microbiota transplantation (FMT)

Fecal microbiota transplantation (FMT) for patients with Clostridium difficile associated diarrhea

Sponsors & Collaborators

  • University of Cologne

    lead OTHER

Principal Investigators

  • Maria Vehreschild, MD · University Hospital of Cologne, Department of Internal Medicine / Infectious Diseases, Cologne, Germany

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2019-03-31
Completion
2019-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02681068 on ClinicalTrials.gov